1. Home
  2. About Us
  3. CEO Message
CEO Message

Along with the growth and development of Indonesia, health has become an increasingly important factor in upgrading the welfare and building the productivity of the nation. Kalbe, as a company in the healthcare industry, keeps on innovating to give the very best to Indonesians. In its journey until today, Kalbe relentlessly innovates to contribute its best for the advancement of the health of the Indonesian people.

Kalbe has contributed to improve health standard of Indonesians, by providing a complete range of products, from prescription pharmaceuticals, over-the-counter drugs, up to consumer health and nutritional products. Driven by a spirit of innovation, Kalbe has transformed from its humble beginning into the largest publicly-listed pharmaceuticals company in Southeast Asia. Kalbe has expanded its portfolio from over-the-counter products, to prescription pharmaceuticals, growing to include consumer health and nutritional products. Kalbe is now building a presence in the medical device and health service, while at the same time developing competence in biotechnology research and development activities.

Such development is in line with Kalbe’s vision to be the best Indonesian healthcare company, driven by innovation, strong brands and excellent management. This also supports Kalbe’s mission to improve health for a better life

Kalbe has a complete portfolio for all income segments, comprising upper, middle and lower segments. Kalbe welcomes the ratification of the Law for a Social Security Provider Body in the implementation of the National Social Security System. To anticipate the implementation of this national healthcare insurance scheme, Kalbe has augmented its generic production facility capacity, to ensure efficient and productive manufacturing, making quality products available at affordable price to all Indonesians. Expansion of its distribution network is also currently underway, as an initiative of Kalbe to ensure and improve product availability throughout Indonesia.

The Company realizes that GCG implementation has direct relevance to the Company’s performance, as the ultimate value of GCG is to improve performance and build a positive image of the Company. Kalbe is fully committed to implement corporate governance at all levels of the organization, based on Good Corporate Governance (GCG) regulations and requirements. The Company has also aligned Kalbe Group culture to GCG principles as formulated in Panca Sradha Kalbe, inherent values derived from the legacy of Kalbe’s Founders.

In line with its mission, Kalbe upholds its commitment to implement its social responsibility through various activities focusing on four main pillars – health, education, environment and infrastructure. As a manifestation of our concerns for the environment, we have implemented ISO 14001:2004 in our production facilities. We continue to improve our efforts to prevent environmental pollution.

Supported by innovation spirit, Kalbe will continue to improve itself to enhance its contribution to all stakeholders, in living and giving values to its mission to improve health for a better life.